(VIANEWS) – Shares of Castle Biosciences (NASDAQ: CSTL) jumped 6.34% to $35.73 at 16:00 EST on Tuesday, following the last session’s upward trend. NASDAQ is sliding 0.15% to $13,747.94, following the last session’s upward trend. This seems, up until now, a somewhat bearish trend trading session today.

Castle Biosciences’s last close was $35.44, 67.09% below its 52-week high of $107.69.


Today’s last reported volume for Castle Biosciences is 202340 which is 16.73% below its average volume of 243019.

Castle Biosciences’s Sales

Castle Biosciences’s sales growth is 53.2% for the ongoing quarter and 39.2% for the next. The company’s growth estimates for the present quarter and the next is a negative 73.9% and a negative 69.6%, respectively.

Castle Biosciences’s Revenue

Year-on-year quarterly revenue growth grew by 31%, now sitting on 68.04M for the twelve trailing months.


Castle Biosciences’s last week, last month’s, and last quarter’s current intraday variation average was 0.77%, 0.22%, and 3.59%, respectively.

Castle Biosciences’s highest amplitude of average volatility was 2.28% (last week), 3.74% (last month), and 3.59% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Castle Biosciences’s stock is considered to be oversold (<=20).

Castle Biosciences’s Stock Yearly Top and Bottom Value

Castle Biosciences’s stock is valued at $35.73 at 16:00 EST, under its 52-week low of $39.34.

Castle Biosciences’s Moving Average

Castle Biosciences’s value is way under its 50-day moving average of $54.83 and way under its 200-day moving average of $64.52.

More news about Castle Biosciences (CSTL).


Please enter your comment!
Please enter your name here